Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: An Open-Label, Multicentre, Single-Treatment-Arm Study

Author： Graff Gavin R.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.30, Iss.6, 2010-06, pp. : 351-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Tolerability of Lacosamide in the Concomitant Treatment of 130 Patients Under 16 Years of Age with Refractory Epilepsy: A Prospective, Open-Label, Observational, Multicenter Study in Spain

By Casas-Fernández Carlos  

Drugs in R&D, Vol. 12, Iss. 4, 2012-12 ,pp. : 187-197

Adis International

Access to resources Recommend Favorite

Long-Term Assessment of Topiramate for Epilepsy: An Open-Label, Single-Arm, Multicentre, Prospective Study in a Naturalistic Setting

By Hufnagel Andreas  

Clinical Drug Investigation, Vol. 31, Iss. 11, 2011-11 ,pp. : 779-790

Adis International

Access to resources Recommend Favorite

Use of Recombinant Human Parathyroid Hormone(1-84) in Patients with Postmenopausal Osteoporosis: A Prospective, Open-Label, Single-Arm, Multicentre, Observational Cohort Study of the Effects of Treatment on Quality of Life and Pain - the PROPOSE Study

By Möricke Rüdiger  

Clinical Drug Investigation, Vol. 31, Iss. 2, 2011-02 ,pp. : 87-99

Adis International

Access to resources Recommend Favorite

Blood Pressure-Lowering Efficacy of an Olmesartan Medoxomil/Hydrochlorothiazide-Based Treatment Algorithm in Elderly Patients (Age ≥65 Years) Stratified by Age, Sex and Race: Subgroup Analysis of a 12-Week, Open-Label, Single-Arm, Dose-Titration Study

By Neutel Joel  

Drugs & Aging, Vol. 28, Iss. 6, 2011-06 ,pp. : 477-490

Adis International

Access to resources Recommend Favorite

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study

By Rogers S.L.   Doody R.S.   Pratt R.D.   Ieni J.R.  

European Neuropsychopharmacology, Vol. 10, Iss. 3, 2000-05 ,pp. : 195-203

Elsevier

Access to resources Recommend Favorite